New Covid vaccine approved by US FDA: Here’s all about it

The US FDA has approved Moderna’s new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for adults 65 and older, and individuals aged 12-64 with underlying risk factors. Moderna’s CEO, Stéphane Bancel, highlighted its importance as a tool against severe COVID-19, noting over 47,000 American deaths in 2024.